$SCL

Stepan to Announce Second Quarter 2026 Results on July 29, 2026

Stepan Company (NYSE: SCL) will release its second-quarter 2026 earnings on July 29, 2026 at about 7:00 a.m. ET, with investor slides posted the same time. The company will host a conference call at 9:00 a.m. ET led by CEO Luis E. Rojo and CFO Ruben Velasquez, with a webcast and replay available.

Original reporting
Published Jul 8, 2026, 11:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 11:49 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stepan to Announce Second Quarter 2026 Results on July 29, 2026 — source image
Decision brief

The 30-second read

$SCLNeutralMed
01

Why it matters

The main tradable element is the event timing for SCL, which can affect options pricing, hedging decisions, and pre-earnings positioning.

02

Market read

Provides the exact earnings and call schedule for SCL, enabling event-driven planning but no new fundamentals.

03

What to watch

The key driver will be what management says on margins, demand, and any forward outlook during the call; this notice alone does not reveal those details.

Relevance 4/10Novelty 3/10Timing: ahead of the July 29, 2026 pre-market earnings release and 9:00 a.m. ET call

Background

Stepan is a specialty and intermediate chemicals manufacturer, and this PRNewswire item announces the timing of its Q2 2026 earnings release and conference call.

Company-level read

Ticker impact

$SCLNeutralMedium confidence
Context

Stepan (SCL) will release Q2 2026 results on July 29, 2026 at about 7:00 a.m. ET, with a call at 9:00 a.m. ET.

Expected impact

Likely elevated pre-earnings volatility into July 29, with direction dependent on the Q2 print and any commentary on operations.

Evidence & confidence

The article discloses the exact earnings date/time and that management will host a results call, but it provides no financial numbers or guidance changes.

Market effects

Specialty chemicals names may see correlated volatility around earnings calendars, but no sector datapoint is provided here.

Primarily US-focused timing for NYSE-listed Stepan; no regional macro linkage is stated.

No global demand, pricing, or regulatory developments are disclosed beyond the earnings schedule.

Counterpoint

Because the release date is already a calendar item, traders may treat this as low signal unless they expect unusual volatility or have specific positioning into the print.

Key entities

  • Stepan Company

    NYSE-listed specialty chemicals company announcing Q2 2026 earnings timing and call details.

  • Luis E. Rojo

    President and CEO hosting the earnings call.

  • Ruben Velasquez

    Vice President and CFO hosting the earnings call.

Related articles

$SCLMed

Stepan Company Q2 2026 Earnings Call Summary

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

$SCLMedAI 8/10

Stepan Reports Second Quarter 2026 Results

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

$SCLMed

STEPAN CO (SCL): Results of Operations and Financial Condition

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d139905dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Stepan Reports Second Quarter 2026 Results Northbrook, Illinois, July 29, 2026 — Stepan Company (NYSE: SCL) today reported: Second Quarter 2026 Highlights • Reported net income was $22.9 million, up 102% versus the prior ye

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

$SCLHighAI 9/10

Daily NZX update, Wednesday, May 27, 2026

The NZX50 rose 0.7% to extend gains to 3.1% over five days and 3.1% for the month (still down 2.0% over six months; up 4.6% YoY). Kathmandu Holdings jumped 14% and KMD reported Q3 FY26 sales +5.2% YoY and gross margin 58.2% (+258 bps). Vista Group gained 4% on a new five-year Cinemex deal; PaySauce revenue rose 3% to $9.2m.

$GROYMed

Gold Royalty Q2 Earnings Call Highlights

Gold Royalty Corp (GROY) discussed its Q2 earnings call, saying its NSR royalty model is based on revenue and can be insulated from mine operating cost inflation. It maintained 2026 guidance of 7,500 to 9,300 GEOs, with 1H at 44% of the midpoint. It also outlined ramp-up and acquisition updates, including a $6.25M REN NSR add-on and new Nevada royalties.